Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martijn van Noort

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
CPT: Pharmacometrics & Systems Pharmacology|June 4, 2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple MyelomaFernando Carreño, Martijn van Noort, Adekemi Taylor, et al.
Diabetes, Obesity & Metabolism|December 1, 2023
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKDThomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2025
Drug release from docetaxel-entrapped core-crosslinked polymeric micelles: A population pharmacokinetic modelling approach based on clinical dataPascale C S Rietveld, Stijn L W Koolen, Stefan Zeiser, et al.
The Journal of Antimicrobial Chemotherapy|June 29, 2025
Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic modelMidas B Mulder, Martijn van Noort, Robert A de Man, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
CPT: Pharmacometrics & Systems Pharmacology|June 4, 2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple MyelomaFernando Carreño, Martijn van Noort, Adekemi Taylor, et al.
Diabetes, Obesity & Metabolism|December 1, 2023
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKDThomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2025
Drug release from docetaxel-entrapped core-crosslinked polymeric micelles: A population pharmacokinetic modelling approach based on clinical dataPascale C S Rietveld, Stijn L W Koolen, Stefan Zeiser, et al.
The Journal of Antimicrobial Chemotherapy|June 29, 2025
Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic modelMidas B Mulder, Martijn van Noort, Robert A de Man, et al.
Pageof 2